Literatur
- 1
Alakus H, Batur M, Schmidt M. et al .
Variable 18F-fluorodeoxyglucose uptake
in gastric cancer is associated with different levels of GLUT-1
expression.
Nucl Med Commun.
2010;
31
532-538
- 2
Gillham C M, Lucey J A, Keogan M. et al .
(18)FDG uptake during induction chemoradiation
for oesophageal cancer fails to predict histomorphological tumour
response.
Br J Cancer.
2006;
95
1174-1179
- 3
Lordick F, Ruers T, Aust D E. et al .
European Organisation of Research and Treatment
of Cancer (EORTC) Gastrointestinal Group: Workshop on the role of
metabolic imaging in the neoadjuvant treatment of gastrointestinal
cancer.
Eur J Cancer.
2008;
44
1807-1819
- 4
Lordick F, Ott K, Krause B J. et al .
Positronen-Emissions-Tomographie bei Karzinomen
des oberen Gastrointestinaltrakts.
Dtsch Med Wochenschr.
2011;
136
1061-1066
- 5
Schneider P M, Hölscher A H. et al .
Response-evaluation by endoscopy, re-biopsy, and endoscopic
ultrasound does not accurately predict histopathologic regression
following neoadjuvant chemoradiation for esophageal cancer.
Ann
Surg.
2008;
248
902-908
- 6
Vallböhmer D, Hölscher A H, Dietlein M. et al .
18F]-Fluorodeoxyglucose-positron
emission tomography for the assessment of histopathologic response
and prognosis after completion of neoadjuvant chemoradiation in
esophageal cancer.
Ann Surg.
2009;
250
888-894
- 7
van Heijl M, Omloo J M, van Berge H enegouwen MI. et al .
Fluorodeoxyglucose
positron emission tomography for evaluating early response during
neoadjuvant chemoradiotherapy in patients with potentially curable
esophageal cancer.
Ann Surg.
2011;
253
56-63
Prof. Dr. A. H. Hölscher
Direktor der Klinik und Poliklinik für Allgemein-, Viszeral-
und Tumorchirurgie
Universität zu Köln
Kerpenerstraße 62
50937 Köln
Telefon: 0221/4784801
Fax: 0221/4784843
eMail: arnulf.hoelscher@uk-koeln.de
